The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kalra, N., Roy, P., Prasad, S., & Shukla, Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.11.006 · Cited by 93
RetractedCancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“, p53) [131–133].”
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Self-citationModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
AP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,395
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Semenza, G. L. (2004) · Physiology · doi:10.1152/physiol.00001.2004 · Cited by 905
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6509 · Cited by 879
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Tanaka, T., Kohno, H., Suzuki, R., Yamada, Y., Sugie, S., & Mori, H. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01386.x · Cited by 729
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses
Leonard, S. S., Xia, C., Jiang, B.-H., Stinefelt, B., Klandorf, H., Harris, G. K., & Shi, X. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.105 · Cited by 681
Clément, M.-V., Hirpara, J. L., Chawdhury, S.-H., & Pervaiz, S. (1998) · Blood · doi:10.1182/blood.v92.3.996 · Cited by 611
Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans
Hursting, S. D., Lavigne, J. A., Berrigan, D., Perkins, S. N., & Barrett, J. C. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152156 · Cited by 556
Nrf2 as a novel molecular target for chemoprevention
Lee, J.-S., & Surh, Y.-J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.042 · Cited by 516
Self-citationTsai, S., Lin‐Shiau, S., & Lin, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702357 · Cited by 511
New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation
Chen, F., Castranova, V., & Shi, X. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61708-7 · Cited by 473
Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D., & Weinstein, I. B. (2002) · PubMed · Cited by 460
Kode, A., Rajendrasozhan, S., Caito, S., Yang, S.-R., Megson, I. L., & Rahman, I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2007 · Cited by 447
Chen, C.-Y., Jang, J.-H., Li, M.-H., & Surh, Y.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.237 · Cited by 428
Self-citationBanerjee, S., Bueso-Ramos, C., & Aggarwal, B. B. (2002) · PubMed · Cited by 423
Martinez, J., & Moreno, J. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00380-9 · Cited by 408
Bhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
She, Q., Bode, A. M., Ma, W., Chen, N. Y., & Dong, Z. (2001) · PubMed · Cited by 393
Yang, S.-R., Wright, J., Bauter, M., Seweryniak, K., Kode, A., & Rahman, I. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00308.2006 · Cited by 391
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
Gusman, J. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1111 · Cited by 388
Resveratrol, a remarkable inhibitor of ribonucleotide reductase
Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., & Guittet, O. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01572-x · Cited by 383
Mechanism of inhibition of bovine F 1 -ATPase by resveratrol and related polyphenols
Gledhill, J. R., Montgomery, M. G., Leslie, A. G. W., & Walker, J. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706290104 · Cited by 379
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
Garvin, S., Öllinger, K., & Dabrosin, C. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.031 · Cited by 351
Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J. W., Sessoms, A. R., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., et al. (2002) · PubMed · Cited by 344
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Shankar, S. (2007) · Frontiers in Bioscience · doi:10.2741/2432 · Cited by 342
Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gossé, F., Bergmann, C., Seiler, N., & Raul, F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00511-5 · Cited by 341
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
Huang, C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.237 · Cited by 338
Mechanism-based in vitro screening of potential cancer chemopreventive agents
Gerhäuser, C., Klimo, K., Heiss, E., Neumann, I., Gamal-Eldeen, A., Knauft, J., Liu, G.-Y., Sitthimonchai, S., & Frank, N. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00332-9 · Cited by 337
Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K., & Mukhtar, H. (2001) · PubMed · Cited by 318
Kong, A.-N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000652 · Cited by 316
Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-11-3550 · Cited by 306
Delmas, D., Rébé, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304896200 · Cited by 291
Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 283
Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols
Garg, A. K., Buchholz, T. A., & Aggarwal, B. B. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1630 · Cited by 278
Mouria, M., Gukovskaya, A. S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A., & Pandol, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10202 · Cited by 274
Regulation of Angiogenesis by Hypoxia and Hypoxia‐Inducible Factors
Hickey, M. M., & Simon, M. C. (2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76007-0 · Cited by 271
Kundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi349 · Cited by 271
Self-citationAfaq, F., Adhami, V. M., & Ahmad, N. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00014-5 · Cited by 262
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis
Müller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., & Fürstenberger, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192323799 · Cited by 240
Wolter, F., Akoglu, B., Clausnitzer, A., & Stein, J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2197 · Cited by 236
Ciolino, H. P., & Yeh, G. C. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12538-2 · Cited by 233
Molecular mechanism of the chemopreventive effect of resveratrol
Dong, Z. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00330-5 · Cited by 227
Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors
COLLINS, I., & GARRETT, M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.009 · Cited by 220
Dinkova-Kostova, A. T., Holtzclaw, W. D., & Wakabayashi, N. (2005) · Biochemistry · doi:10.1021/bi047434h · Cited by 219
Woo, J.-H., Lim, J. H., Kim, Y.-H., Suh, S.-I., Min, D. S., Chang, J.-S., Lee, Y. H., Park, J.-W., & Kwon, T. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207307 · Cited by 213
Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets
Kundu, J. K., & Surh, Y.-J. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.019 · Cited by 212
Self-citationDelmas, D., Rébé, C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G., Latruffe, N., & Solary, E. (2004) · Oncogene · doi:10.1038/sj.onc.1208086 · Cited by 212
Adhami, V. M., Afaq, F., & Ahmad, N. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80019-2 · Cited by 209
Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism
Shih, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1223 · Cited by 208
Zhang, Q., Tang, X., Lu, Q. Y., Zhang, Z. F., Brown, J., & Le, A. D. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0198 · Cited by 202
Schneider, Y., Duranton, B., Goss, F., Schleiffer, R., Seiler, N., & Raul, F. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc391_14 · Cited by 202
Aziz, M. H., Nihal, M., Fu, V. X., Jarrard, D. F., & Ahmad, N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0526 · Cited by 201
Kundu, J. K., Shin, Y. K., & Surh, Y.-J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.005 · Cited by 193
Self-citationMutoh, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.959 · Cited by 190
Effects of dietary chemopreventive phytochemicals on P-glycoprotein function
Nabekura, T., Kamiyama, S., & Kitagawa, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.081 · Cited by 180
Chen, Z.-H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh183 · Cited by 175
Revel, A., Raanani, H., Younglai, E., Xu, J., Rogers, I., Han, R., Savouret, J., & Casper, R. F. (2003) · Journal of Applied Toxicology · doi:10.1002/jat.916 · Cited by 174
Cao, Z., Fang, J., Xia, C., Shi, X., & Jiang, B.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0588 · Cited by 173
Li, Z. G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1531 · Cited by 169
Mechanisms of Disease: inflammatory mediators and cancer prevention
Mann, J. R., Backlund, M. G., & DuBois, R. N. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0140 · Cited by 167
Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells
Kuo, P.-L., Chiang, L.-C., & Lin, C.-C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02177-x · Cited by 165
Narayanan, B. A., Narayanan, N. K., Re, G. G., & Nixon, D. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.10932 · Cited by 165
Mahyar-Roemer, M., Katsen, A., Mestres, P., & Roemer, K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1516 · Cited by 163
Hudson, T. S., Hartle, D. K., Hursting, S. D., Nunez, N. P., Wang, T. T. Y., Young, H. A., Arany, P., & Green, J. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4069 · Cited by 163
Resveratrol suppresses prostate cancer progression in transgenic mice
Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A., Eltoum, I. A., & Lamartiniere, C. A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm144 · Cited by 160
Hecht, S. S., Kenney, P. M. J., Wang, M., Trushin, N., Agarwal, S., Venket Rao, A., & Upadhyaya, P. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00326-7 · Cited by 159
Reagan-Shaw, S., Afaq, F., Aziz, M. H., & Ahmad, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207666 · Cited by 158
Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review
Fulda, S., & Debatin, K. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.03.007 · Cited by 158
Kowalski, J., Samojedny, A., Paul-Samojedny, M., Pietsz, G., & Wilczok, T. (2005) · PubMed · Cited by 157
Hwang, J., KWAK, D. W., Sun, L., Kim, H. M., KIM, Y. M., & Park, O. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.047 · Cited by 157
Lin, H., Shih, A., Davis, F. B., Tang, H.-Y., Martino, L. J., Bennett, J. A., & Davis, P. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64739-8 · Cited by 157
Heiß, E. H., Schilder, Y. D. C., & Dirsch, V. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703229200 · Cited by 155
Juan, S., Cheng, T., Lin, H., Chu, Y.-L., & Lee, W. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.015 · Cited by 153
Pozo‐Guisado, E., Lorenzo‐Benayas, M. J., & Fernández‐Salguero, P. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11720 · Cited by 150
Resveratrol inhibits glucose metabolism in human ovarian cancer cells
Kueck, A. S., Opipari, A. W., Griffith, K. A., Tan, L., Choi, M., Huang, J. T., Wahl, H. N., & Liu, J. R. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.065 · Cited by 149
Kundu, J. K., & Surh, Y. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.04.019 · Cited by 145
Self-citationTyagi, A., Singh, R. P., Agarwal, C., Siriwardana, S., Sclafani, R. A., & Agarwal, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi165 · Cited by 145
Integrin αVβ3 contains a receptor site for resveratrol
Lin, H., Lansing, L., Mérillon, J., Davis, F. B., Tang, H., Shih, A., Vitrac, X., Krisa, S., Keating, T., Cao, H., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5743fje · Cited by 145
Chang, T. K. H., Chen, J., & Lee, W. B. K. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29205-3 · Cited by 145
Yu, R., Hebbar, V., Kim, D. W., Mandlekar, S., Pezzuto, J. M., & Kong, A.-N. T. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.217 · Cited by 140
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells
Sexton, É., Themsche, C. V., Leblanc, K., Parent, S., Lemoine, P., & Asselin, É. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-45 · Cited by 131
Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF- B
Chun, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh021 · Cited by 129
The Red Wine Polyphenol Resveratrol Displays Bilevel Inhibition on Aromatase in Breast Cancer Cells
Wang, Y., Lee, K. W., Chan, F. L., Chen, S., & Leung, L. K. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj190 · Cited by 125
Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells
Kim, Y., Choi, B. T., Lee, Y. S., Park, D. J., Rhee, S., Park, K.-Y., & Choi, Y. (2004) · Oncology Reports · doi:10.3892/or.11.2.441 · Cited by 123
Kluth�, D., Banning, A., Paur, I., Blomhoff, R., & Brigelius‐Flohé, R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.028 · Cited by 122
Tang, H.-Y., Shih, A., Cao, H., Davis, F. B., Davis, P. J., & Lin, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0216 · Cited by 120
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G. V., & Comi, P. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.001 · Cited by 117
Effect of Resveratrol on Growth of 4T1 Breast Cancer Cells in Vitro and in Vivo
Bove, K., Lincoln, D. W., & Tsan, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6554 · Cited by 117
Toxicogenomics of resveratrol in rat liver
Hebbar, V., Shen, G., Hu, R., Kim, B.-R., Chen, C., Korytko, P. J., Crowell, J. A., LEVINE, B. S., & Kong, A.-N. T. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.039 · Cited by 115
Murakami, A., Matsumoto, K., Koshimįzu, K., & Ohigashi, H. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00058-2 · Cited by 114
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors
North, S., Moenner, M., & Bikfalvi, A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.007 · Cited by 113
WU, J. M., Hsieh, T., Lu, X., & Wang, Z. (2006) · Medicinal Chemistry · doi:10.2174/157340606776930709 · Cited by 107
Hypoxia enhances LPA-induced HIF-1α and VEGF expression: Their inhibition by resveratrol
Park, S. Y., Jeong, K. J., Lee, J., Yoon, D. S., Choi, W. S., Kim, Y. K., Han, J. W., Kim, Y. M., Kim, B. K., & Lee, H. Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.011 · Cited by 105
Rezk, Y. A., Balulad, S. S., Keller, R. S., & Bennett, J. A. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.11.030 · Cited by 105
Niles, R. M., Cook, C. P., Meadows, G. G., Fu, Y., McLaughlin, J. L., & Rankin, G. O. (2006) · Journal of Nutrition · doi:10.1093/jn/136.10.2542 · Cited by 104
Activation Loop Phosphorylation Controls Protein Kinase D-Dependent Activation of Nuclear Factor κB
Störz, P., Döppler, H. R., & Toker, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000687 · Cited by 102
Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells
Mahyar-Roemer, M., Köhler, H., & Roemer, K. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-27 · Cited by 100
Murugan, S., & Nalini, N. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061789 · Cited by 99
Gill, C., Walsh, S. E., Morrissey, C. M., Fitzpatrick, J. M., & Watson, R. W. G. (2007) · The Prostate · doi:10.1002/pros.20653 · Cited by 98
Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00445.x · Cited by 98
Involvement of c‐jun NH2‐terminal kinases in resveratrol‐induced activation of p53 and apoptosis
She, Q., Huang, C., Zhang, Y., & Dong, Z. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10041 · Cited by 97
Azios, N. G., & Dharmawardhane, S. F. (2005) · Neoplasia · doi:10.1593/neo.04346 · Cited by 96
Ulrich, S., Loitsch, S. M., Rau, O., von Knethen, A., Brüne, B., Schubert-Zsilavecz, M., & Stein, J. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2777 · Cited by 95
Li, Y., Liu, J., Liu, X., Xing, K., Wang, Y., Li, F., & Yao, L. (2006) · Applied Biochemistry and Biotechnology · doi:10.1385/abab:135:3:181 · Cited by 95
Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice
Zhou, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i2.280 · Cited by 93
Resveratrol Inhibits Cyclooxygenase‐2 Transcription in Human Mammary Epithelial Cells
Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., TELANG, N. T., & Dannenberg, A. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08737.x · Cited by 93
Sun, C., Hu, Y., Liu, X., Wu, T., Wang, Y., He, W., & Wenning, W. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.06.016 · Cited by 92
Richard, N., Porath, D., Radspieler, A., & Schwager, J. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400099 · Cited by 91
Tanaka, T., Suzuki, R., Kohno, H., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh292 · Cited by 87
Stewart, J. R., & O’Brian, C. A. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000011787.75522.ec · Cited by 86
Andrieux, L. O., Langouët, S., Fautrel, A., Ezan, F., Krauser, J. A., Savouret, J. F., Guengerich, F. P., Baffet, G., & Guillouzo, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.934 · Cited by 85
Atten, M. J., Attar, B. M., Milson, T., & Holian, O. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00788-2 · Cited by 84
Adhami, V. M., Afaq, F., & Ahmad, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5819 · Cited by 83
Lee, S. C., Chan, J. Y., Clement, M., & Pervaiz, S. (2006) · PROTEOMICS · doi:10.1002/pmic.200500366 · Cited by 83
Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model
Busquets, S., Ametller, E., Fuster, G., Oliván, M., Raab, V., Argilés, J. M. A., & López-Soriano, F. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.035 · Cited by 81
Mohan, J., Gandhi, A. A., Bhavya, B. C., Rashmi, R., Karunagaran, D., Indu, R., & Santhoshkumar, T. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602641200 · Cited by 80
Kundu, J. K., Chun, K., Kim, S. O., & Surh, Y. (2004) · BioFactors · doi:10.1002/biof.552210108 · Cited by 79
Self-citationModulating Cell Cycle: Current Applications and Prospects for Future Drug Development
Gali‐Muhtasib, H. U., & Bakkar, N. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023333809 · Cited by 78
Dietary Resveratrol Does Not Affect Intestinal Tumorigenesis in Apc/+ Mice
Ziegler, C. C., Whelan, J., Rainwater, L., & McEntee, M. F. (2004) · Journal of Nutrition · doi:10.1093/jn/134.1.5 · Cited by 76
Fulda, S., & Debatin, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.020 · Cited by 74
Ahmad, K. A., Harris, N. H., Johnson, A. D., Lindvall, H. C. N., Wang, G., & Ahmed, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0491 · Cited by 72
Tang, F.-Y., Chiang, E. I., & Sun, Y.-C. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.03.003 · Cited by 69
Antiproliferative Effect of Resveratrol in Human Prostate Carcinoma Cells
Kim, Y., Rhee, S., Park, K., & Choi, Y. H. (2003) · Journal of Medicinal Food · doi:10.1089/109662003772519813 · Cited by 65
Miura, D., Miura, Y., & Yagasaki, K. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-2698-1 · Cited by 59
Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells
Shen, F., Chen, S., Dong, X., Zhong, H., Li, Y.-T., & Cheng, G.-F. (2003) · Journal of Asian Natural Products Research · doi:10.1080/1028602031000066852 · Cited by 58
Sun, C., Hu, Y., Guo, T., Wang, H., ZHANG, X.-P., He, W., & Tan, H. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00343.x · Cited by 57
Alkhalaf, M. (2007) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000228413.06471.4c · Cited by 57
She, Q., Ma, W., Wang, M., Kaji, A., Ho, C., & Dong, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206370 · Cited by 57
Terada, Y., Inoshita, S., Nakashima, O., Kuwahara, M., Sasaki, S., & Marumo, F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00704.x · Cited by 54
Hypoxia-Inducible Factor 1 as a Possible Target for Cancer Chemoprevention
López‐Lázaro, M. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0369 · Cited by 47
TGF-βbgr-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells
Terada, Y., Nakashima, O., Inoshita, S., Kuwahara, M., Sasaki, S., & Marumo, F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00665.x · Cited by 39
Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells.
Li, Y.-T., Shen, F., Liu, B.-H., & Cheng, G.-F. (2003) · PubMed · Cited by 39
Millán, O., Rico, D., Peinado, H., Zarich, N., Stamatakis, K., Pérez‐Sala, D., Rojas, J. M., Cano, A., & Boscá, L. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi213 · Cited by 33
Kohno, H., Takahashi, M., Yasui, Y., Suzuki, R., Miyamoto, S., Kamanaka, Y., Naka, M., Maruyama, T., Wakabayashi, K., & Tanaka, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22736 · Cited by 31
Neves, M. A. C., Dinis, T. C. P., Colombo, G., & Melo, M. L. S. E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700149 · Cited by 31
Ulrich, S., Huwiler, A., Loitsch, S. M., Schmidt, H., & Stein, J. M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.001 · Cited by 29
Tang, Z., Liu, X., & Zou, P. (2007) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-007-0508-0 · Cited by 15
Resveratrol: A whiff that induces a biologically specific tsunami
Pezzuto, J. M. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.9.1129 · Cited by 14
Cited by
Dietary phenolics: chemistry, bioavailability and effects on health
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 1,988
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,129
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Potential Adverse Effects of Resveratrol: A Literature Review
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062084 · Cited by 716
Administration of resveratrol: What formulation solutions to bioavailability limitations?
Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 620
Metadata
- Authors
- Kundu, J. K., & Surh, Y.-J.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 269
- Issue
- 2
- Pages
- 243-261
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2135783745
- Cited by
- 473
- References
- 150
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.